The Outsourcing Of Rd Through Acquisition In The Pharmaceutical Industry

Download The Outsourcing Of Rd Through Acquisition In The Pharmaceutical Industry full books in PDF, epub, and Kindle. Read online The Outsourcing Of Rd Through Acquisition In The Pharmaceutical Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

The Outsourcing of R&D Through Acquisition in the Pharmaceutical Industry

Author : Matthew John Higgins
Publisher :
ISBN 13 :
Total Pages : 0 pages
Book Rating : 4.:/5 (137 download)

DOWNLOAD NOW!

Book Synopsis The Outsourcing of R&D Through Acquisition in the Pharmaceutical Industry by : Matthew John Higgins

Download or read book The Outsourcing of R&D Through Acquisition in the Pharmaceutical Industry written by Matthew John Higgins and published by . This book was released on 2015 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: We examine the performance of 160 pharmaceutical acquisitions from 1994 to 2001 and find evidence that on average acquirers realize significant positive returns. These returns are positively correlated with prior acquirer access to information about the research and development activities at target firms and a superior negotiating position. A unique Desperation Index is employed to determine the current status of a firm's internal productivity. We find that firms experiencing declines in internal productivity or which are more desperate are more likely to engage in an outsourcing-type acquisition in an effort to replenish their research pipelines.

Outsourcing of R&D in the Pharmaceutical Industry

Author : Bianca Piachaud
Publisher : Springer
ISBN 13 : 0230512631
Total Pages : 205 pages
Book Rating : 4.2/5 (35 download)

DOWNLOAD NOW!

Book Synopsis Outsourcing of R&D in the Pharmaceutical Industry by : Bianca Piachaud

Download or read book Outsourcing of R&D in the Pharmaceutical Industry written by Bianca Piachaud and published by Springer. This book was released on 2004-09-30 with total page 205 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book examines the strategic aspects of outsourcing in relation to the firm. It provides a holistic view of the outsourcing process, starting with conceptualisation, through to implementation and management of the process. Although the book is based on a case study of the pharmaceutical industry, the general principles derived from the Strategic Sourcing Model are generic in nature and the model can be applied to instances of outsourcing in other industries.

Mergers and Acquisitions in Pharmaceuticals - Why and How?

Author : R. D. Neirinckx
Publisher : Rudi Neirinckx
ISBN 13 : 186067464X
Total Pages : 201 pages
Book Rating : 4.8/5 (66 download)

DOWNLOAD NOW!

Book Synopsis Mergers and Acquisitions in Pharmaceuticals - Why and How? by : R. D. Neirinckx

Download or read book Mergers and Acquisitions in Pharmaceuticals - Why and How? written by R. D. Neirinckx and published by Rudi Neirinckx. This book was released on 2000-02 with total page 201 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Mergers & Acquisitions in the Contract Research Organization Industry

Author : Jakob Miera
Publisher : GRIN Verlag
ISBN 13 : 3656515379
Total Pages : 92 pages
Book Rating : 4.6/5 (565 download)

DOWNLOAD NOW!

Book Synopsis Mergers & Acquisitions in the Contract Research Organization Industry by : Jakob Miera

Download or read book Mergers & Acquisitions in the Contract Research Organization Industry written by Jakob Miera and published by GRIN Verlag. This book was released on 2013-10-10 with total page 92 pages. Available in PDF, EPUB and Kindle. Book excerpt: Master's Thesis from the year 2013 in the subject Business economics - Business Management, Corporate Governance, grade: 1,0, , language: English, abstract: This thesis deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these admission, money and time pressures, pharmaceutical companies are looking for an alternative in the drug development process. A very popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). Contract Research Organizations are specialized in coordination and monitoring of drug development activities. Due to their focus they often offer a more sophisticated and faster process. Demographic changes, chronic diseases like cancer and diabetes, and completely new cluster of symptoms demand new therapeutically treatments. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 – 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. To benefit from the good industry outlooks CROs adjust their service offerings and strengthen their competitive situation. More and more Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives. Since couple of years we can observe an increased number of deals. Large corporations can close the gaps in the internal service pipeline and smaller firms can use mergers as a financial exit. However, many M&A activities are considered as ineffective and contra-productive for the shareholder value – either destroy or merely add. Depending on the study, the numbers of M&A failures vary from 50% to even 80%. Possible reasons may be not enough integration planning and unrealistic expectations on the cost and time. The reality shows that it is not that easy to cut costs by simple combining two departments after a merger or acquisition. Additionally, we can see that mergers and acquisitions basically not succeed during the actual process.[...]

Pharmaceutical Outsourcing: Discovery and Preclinical Services

Author : William C. Stevens Jr.
Publisher : Lulu.com
ISBN 13 : 0984904905
Total Pages : 277 pages
Book Rating : 4.9/5 (849 download)

DOWNLOAD NOW!

Book Synopsis Pharmaceutical Outsourcing: Discovery and Preclinical Services by : William C. Stevens Jr.

Download or read book Pharmaceutical Outsourcing: Discovery and Preclinical Services written by William C. Stevens Jr. and published by Lulu.com. This book was released on 2011 with total page 277 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pharmaceutical Outsourcing: Discovery and Preclinical Services is the first in a series on pharmaceutical outsourcing. This first book is written for all practitioners in the pharmaceutical and biotech world and is about managing projects in drug discovery and preclinical development. The purpose envisioned by the authors and editors is to provide an understanding of how outsourcing works from the perspective of sponsor, internal customer, service provider, outsourcing service marketplace, principal investigator, project leader, and consultant. The authors of this book and the companies they represent hail from the Americas, Europe, Asia, and Australia, underscoring the fact that drug discovery is an international effort. The scope of the businesses covered include the one-person consulting company through to a sponsor among the largest in the industry. Written in the styles unique to each author, the reader will enjoy getting into the minds of the writer. Our intention is to provide a story for each aspect of the process as you move from target validation, genomic profiling, screening, medicinal chemistry, modeling and informatics, safety evaluation, therapeutic target confirmation, through to protecting the results of the research, the intellectual property. Emerging trends in drug discovery support a rapidly growing business model in outsourcing, the virtual pharma company. In recognition of this important element are several success stories and learnings on arbitraging risks in discovery. Outsourcing provides the ultimate flexibility in managing projects that may quickly grow, progress in directions unanticipated, or fail early. Last but not least, this book provides insights in working with companies outside your region, with business cultures unfamiliar or unknown. Relationship building is about understanding your sponsor or customer in their cultural space and being able to establish the rapport for clear and open communications. Priceless!

CRO – Contract Research Organization: How Drug Research is Evolving

Author : Jakob Miera
Publisher : Anchor Academic Publishing (aap_verlag)
ISBN 13 : 3954896982
Total Pages : 90 pages
Book Rating : 4.9/5 (548 download)

DOWNLOAD NOW!

Book Synopsis CRO – Contract Research Organization: How Drug Research is Evolving by : Jakob Miera

Download or read book CRO – Contract Research Organization: How Drug Research is Evolving written by Jakob Miera and published by Anchor Academic Publishing (aap_verlag). This book was released on 2014-02-01 with total page 90 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these facts pharmaceutical companies are looking for an alternative in the drug development process. A popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). CRO are specialized in coordination and monitoring of drug development activities. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 – 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives.

Mergers & Acquisitions in the Contract Research Organization Industry

Author : Jakob Miera
Publisher :
ISBN 13 : 9783656515432
Total Pages : 96 pages
Book Rating : 4.5/5 (154 download)

DOWNLOAD NOW!

Book Synopsis Mergers & Acquisitions in the Contract Research Organization Industry by : Jakob Miera

Download or read book Mergers & Acquisitions in the Contract Research Organization Industry written by Jakob Miera and published by . This book was released on 2013-10 with total page 96 pages. Available in PDF, EPUB and Kindle. Book excerpt: Master's Thesis from the year 2013 in the subject Business economics - Business Management, Corporate Governance, grade: 1,0, language: English, abstract: This thesis deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these admission, money and time pressures, pharmaceutical companies are looking for an alternative in the drug development process. A very popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). Contract Research Organizations are specialized in coordination and monitoring of drug development activities. Due to their focus they often offer a more sophisticated and faster process. Demographic changes, chronic diseases like cancer and diabetes, and completely new cluster of symptoms demand new therapeutically treatments. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 - 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. To benefit from the good industry outlooks CROs adjust their service offerings and strengthen their competitive situation. More and more Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives. Since couple of years we can observe an increased number of deals. Large corporations can close the gaps in the internal service pipeline and smaller firms can use mergers as a financial exit. However, many

Outsourcing Biopharma R&D to India

Author : P R Chowdhury
Publisher : Elsevier
ISBN 13 : 1908818018
Total Pages : 133 pages
Book Rating : 4.9/5 (88 download)

DOWNLOAD NOW!

Book Synopsis Outsourcing Biopharma R&D to India by : P R Chowdhury

Download or read book Outsourcing Biopharma R&D to India written by P R Chowdhury and published by Elsevier. This book was released on 2011-05-05 with total page 133 pages. Available in PDF, EPUB and Kindle. Book excerpt: The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology companies have made India their choice for a research destination. Initially R&D was inclined more towards developing products for the Indian market within the country. This led to several multinational companies opening up production plants in India, primarily due to the globalization of the Indian economy and offshoring jobs to India. Alongside, several global pharma-biotech majors ascertained large market requirements within the country and capitalized on the advantage of serving Indian customers. Strategies were devised to optimize operational expenses with the setting up of on-site R&D to develop products for local requirements. In view of this, this book seeks to explore various nuances of the outsourcing sector with respect to biopharma in India. Constitutes the first ever comprehensive insight on the Indian biopharma sector Provides a perspective based on practical hands-on legal experience Simply structured, clearly presented and free from excessive legal jargon

Research and Development in the Pharmaceutical Industry (A CBO Study)

Author : Congressional Budget Office
Publisher : Lulu.com
ISBN 13 : 1304121445
Total Pages : 65 pages
Book Rating : 4.3/5 (41 download)

DOWNLOAD NOW!

Book Synopsis Research and Development in the Pharmaceutical Industry (A CBO Study) by : Congressional Budget Office

Download or read book Research and Development in the Pharmaceutical Industry (A CBO Study) written by Congressional Budget Office and published by Lulu.com. This book was released on 2013-06-09 with total page 65 pages. Available in PDF, EPUB and Kindle. Book excerpt: Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...

Outsourcing in the Pharmaceutical Industry

Author : Patrick Taaffe
Publisher :
ISBN 13 : 9781853346132
Total Pages : 116 pages
Book Rating : 4.3/5 (461 download)

DOWNLOAD NOW!

Book Synopsis Outsourcing in the Pharmaceutical Industry by : Patrick Taaffe

Download or read book Outsourcing in the Pharmaceutical Industry written by Patrick Taaffe and published by . This book was released on 1996 with total page 116 pages. Available in PDF, EPUB and Kindle. Book excerpt:

The Oxford Handbook of the Economics of the Biopharmaceutical Industry

Author : Patricia M. Danzon
Publisher : OUP USA
ISBN 13 : 0199742995
Total Pages : 618 pages
Book Rating : 4.1/5 (997 download)

DOWNLOAD NOW!

Book Synopsis The Oxford Handbook of the Economics of the Biopharmaceutical Industry by : Patricia M. Danzon

Download or read book The Oxford Handbook of the Economics of the Biopharmaceutical Industry written by Patricia M. Danzon and published by OUP USA. This book was released on 2012-04-24 with total page 618 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume examines the economics of the biopharmaceutical industry, with eighteen chapters by health economists.

The Handbook of Mergers and Acquisitions

Author : David Faulkner
Publisher : Oxford University Press, USA
ISBN 13 : 0199601461
Total Pages : 773 pages
Book Rating : 4.1/5 (996 download)

DOWNLOAD NOW!

Book Synopsis The Handbook of Mergers and Acquisitions by : David Faulkner

Download or read book The Handbook of Mergers and Acquisitions written by David Faulkner and published by Oxford University Press, USA. This book was released on 2012-06-07 with total page 773 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Handbook bridges hitherto separate disciplines engaged in research in mergers and acquisitions (M&A) to integrate strategic, financial, socio-cultural, and sectoral approaches to the field. It examines the management processes involved, as well as valuations and post-acquisition performance, and considers international and sectoral dimensions.

Modern Strategy for Preclinical Pharmaceutical R&D

Author : David Cavalla
Publisher : John Wiley & Sons
ISBN 13 : 9780471971177
Total Pages : 232 pages
Book Rating : 4.9/5 (711 download)

DOWNLOAD NOW!

Book Synopsis Modern Strategy for Preclinical Pharmaceutical R&D by : David Cavalla

Download or read book Modern Strategy for Preclinical Pharmaceutical R&D written by David Cavalla and published by John Wiley & Sons. This book was released on 1997-10-07 with total page 232 pages. Available in PDF, EPUB and Kindle. Book excerpt: The twentieth century has been a great success for modern medicine, and has resulted in the generation of a plethora of drugs to treat most common illnesses. However, in the light of increasing regulatory demands, spiralling costs and diminishing commercial returns, the question of how, when, where and whether to conduct pharmaceutical R&D has profound implications, and not just for those within the pharmaceutical industry. In response to these and other dilemmas, the authors define the processes involved in drug research, and examine the advantages and disadvantages of collaborative methods of drug research, and examine the roles that academia, CROs, small "biotechnology" companies and "research boutiques," and possibly even the "virtual research company" might play as contractors and collaborators.

The Outsourcing R&D Toolkit

Author : Peter A. Sammons
Publisher : Gower Publishing, Ltd.
ISBN 13 : 0566083140
Total Pages : 260 pages
Book Rating : 4.5/5 (66 download)

DOWNLOAD NOW!

Book Synopsis The Outsourcing R&D Toolkit by : Peter A. Sammons

Download or read book The Outsourcing R&D Toolkit written by Peter A. Sammons and published by Gower Publishing, Ltd.. This book was released on 2000 with total page 260 pages. Available in PDF, EPUB and Kindle. Book excerpt: Research and Development (R&D) is a key 'factor of production' in the global business environment and yet there can be no doubt that research budgets are under attack as never before. International competitive pressure means that companies, and countries, must innovate or die even though funding is often decreasing. The answer to this dichotomy is to ensure better value for money - and this toolkit will lead you towards that goal. The Outsourcing R&D Toolkit comprehensively covers the strategic and tactical issues necessary for a company to decide whether, and to what extent, to buy in their knowledge-based services. Having done this it then goes on to provide a toolbox of commercial materials to enable better control of external R&D projects. It consists of two main Parts: [ Part I: Buying Research Services - this provides an up-to-date briefing on contract R&D, practices, procedures and pitfalls. It includes 70] learning points which highlight issues particularly important to companies buying-in R&D services. [ Part II: Contract Research Toolbox of template contract and contract management documents including instructions for use: these materials are subtly tailored to the commercial interests of the knowledge buyer and form a contracting system in their own right. They may also be used to benchmark existing company practices and procedures. Buying in R&D services is undoubtedly the way of the future and a core management competence across all industrial sectors. The Outsourcing R&D Toolkit will stop you from being left behind!

The Economics of Corporate Governance and Mergers

Author : K. Gugler
Publisher : Edward Elgar Publishing
ISBN 13 : 1848443927
Total Pages : 373 pages
Book Rating : 4.8/5 (484 download)

DOWNLOAD NOW!

Book Synopsis The Economics of Corporate Governance and Mergers by : K. Gugler

Download or read book The Economics of Corporate Governance and Mergers written by K. Gugler and published by Edward Elgar Publishing. This book was released on 2008-01-01 with total page 373 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides an insightful view of major issues in the economics of corporate governance (CG) and mergers. It presents a systematic update on the developments in the two fields during the last decade, as well as highlighting the neglected topics in CG research, such as the role of boards, CG and public interest and the relation of CG to mergers. Two important conclusions can be drawn from this book: the first is that corporate governance systems that better align shareholders and managers interests lead to better corporate performance; second, there is an important relationship between CG structures and the quality of firm decision-making, one of the most important being the decision to merge or take over another firm. Focusing on some of the often-neglected aspects of corporate governance such as non-profit organizations and public interest, as well as mergers and acquisitions from a CG perspective, this book will be a valuable resource for both academics and postgraduate students of finance, business and economics.

Global Issues in Pharmaceutical Marketing

Author : Lea Prevel Katsanis
Publisher : Routledge
ISBN 13 : 1136313303
Total Pages : 193 pages
Book Rating : 4.1/5 (363 download)

DOWNLOAD NOW!

Book Synopsis Global Issues in Pharmaceutical Marketing by : Lea Prevel Katsanis

Download or read book Global Issues in Pharmaceutical Marketing written by Lea Prevel Katsanis and published by Routledge. This book was released on 2015-07-16 with total page 193 pages. Available in PDF, EPUB and Kindle. Book excerpt: Global Issues in Pharmaceutical Marketing presents a balanced, research-based perspective combined with a practical outlook on the current issues faced by the ethical, biotech, and generic segments of the pharmaceutical industry. It integrates an analytical approach with a global view to examine such issues as market access, digital marketing, emerging markets, branding, and more. The book covers not only the North American and Western European markets, but focuses on non-Western markets, such as Latin America and Asia. Each chapter is written as an individual essay about a given issue, and where relevant, original cases are provided to illustrate how these issues are currently managed by the global industry. This book offers a thoughtful and thorough description of the industry’s current situation and integrates the latest scholarly and industry research from different disciplines in one place for convenient reference. It may be used in the following ways: To stimulate class discussions and inspire new streams of research for academics and graduate students; To introduce the industry to those interested in a career, to orient new industry hires, or to provide experienced practitioners with current research that will enhance their knowledge; To provide an understanding of the industry for those in the healthcare sector, such as physicians, pharmacists, as well as medical and pharmacy students; and To present recent and relevant research for those in government, public or private payers, and public policy environments to facilitate their decision making. This book will prove to be a useful resource and an important source of information for academics and their students, professionals, and policymakers around the world.

Innovation and Marketing in the Pharmaceutical Industry

Author : Min Ding
Publisher : Springer Science & Business Media
ISBN 13 : 1461478014
Total Pages : 763 pages
Book Rating : 4.4/5 (614 download)

DOWNLOAD NOW!

Book Synopsis Innovation and Marketing in the Pharmaceutical Industry by : Min Ding

Download or read book Innovation and Marketing in the Pharmaceutical Industry written by Min Ding and published by Springer Science & Business Media. This book was released on 2013-10-31 with total page 763 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.